Eloralintide
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
Eloralintide, also known by the development code LY3841136, is an investigational selective amylin-receptor agonist. SKU ELOR5 specifies 5 mg per vial and 10 vials per box. It is relevant to research on amylin-receptor signaling and metabolic regulation. Published studies of the clinical development candidate provide scientific context but do not establish the identity, quality or clinical suitability of a third-party research lot. For laboratory research only; not for human or veterinary use.
No published certificates yet.
SKU y presentación
| SKU | Por vial | Viales por caja | Precio de la caja |
|---|---|---|---|
| ELOR5 | 5 mg | 10 | 410,00 US$ |
Las cantidades nominales describen la etiqueta; los resultados medidos figuran en cada informe. Un informe publicado no confirma el lote asignado a un pedido futuro.
Preguntas sobre el producto y la documentación
¿Cómo interpreto el tamaño y la cantidad?
La cantidad por vial y los viales por caja aparecen por separado. El precio corresponde a una caja. En mezclas, el tamaño puede ser combinado; consulte la etiqueta y el informe para cada componente.
¿Cómo encuentro el COA correspondiente?
Compare producto, SKU y número de lote. La página del lote muestra resultados, informe original y enlace de verificación. Consulte al soporte si su pedido no indica el lote asignado.
¿Un resultado de pureza significa que se aprobaron todas las pruebas?
No. Identidad, pureza, llenado y endotoxinas son mediciones distintas. Revise cada resultado y unidad. Un resultado ausente no equivale a aprobado, y un valor inferior a un límite no es cero.
Research Information
Eloralintide is studied as a selective amylin-receptor agonist in mechanistic and clinical development programs. Relevant laboratory questions include receptor pharmacology, downstream signaling and comparative assay responses. Literature concerning the investigational candidate must be distinguished from lot-specific analytical evidence for the catalog material.
Eloralintide Research & Studies
Identity and SKU
Eloralintide is the development name associated with LY3841136, an investigational selective amylin-receptor agonist. SKU ELOR5 specifies 5 mg per vial, with 10 vials per box. The development code is a compound identifier, not proof of a research lot identity.
Amylin-receptor research
The published discovery program describes selective amylin-receptor agonism and clinical proof of concept. This supports research questions concerning receptor pharmacology and metabolic signaling. Experimental comparisons should use appropriately characterized materials and clearly defined receptor assay systems.
Published development evidence
A randomized phase 2 study and a separate discovery and clinical proof-of-concept publication are available for the investigational candidate. These sources describe a controlled development program, not testing of this catalog lot. They should not be interpreted as approval or as evidence that this research product is suitable for administration.
Analytical and experimental considerations
Confirm peptide identity and content with lot-specific analytical documentation before comparing biological assay results. Distinguish receptor-level response from whole-system metabolic outcomes, and document controls and assay conditions. The catalog quantity is a nominal specification rather than an independently established purity result.
Frequently Asked Questions
What is the alternative name?
LY3841136 is the development code associated with eloralintide.
What does ELOR5 specify?
The SKU specifies 5 mg per vial and 10 vials per box.
What pathway is it studied in?
Amylin-receptor signaling and related metabolic regulation are the principal research context.
Do clinical publications validate this product lot?
No. Published trials concern the investigational development candidate; this catalog material requires its own identity and analytical documentation.
Learn more
Read research overviews, COA verification guides, and reconstitution notes in our Knowledge Hub.